A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma

OBJECTIVE: Despite the availability of new agents, elderly patients with multiple myeloma (MM) usually present with poor outcomes due to the heterogeneity of disease conditions, especially immune deficiency. Regulatory B cells (Bregs) can be involved in immune defects by exerting immune regulatory f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wenjiao, Li, Yan, Zou, Zhongqing, Cui, Jian, Wang, Fangfang, Zheng, Yuhuan, Hou, Li, Pan, Ling, Xiang, Bing, Chang, Hong, Zhang, Li, Niu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939179/
https://www.ncbi.nlm.nih.gov/pubmed/36127626
http://dx.doi.org/10.1002/cam4.5228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939179/
https://www.ncbi.nlm.nih.gov/pubmed/36127626
http://dx.doi.org/10.1002/cam4.5228

Ejemplares similares